Tetracycline inhibits Porphyromonas gingivalis lipopolysaccharide-induced lesions in vivo and TNfα processing in vitro

Journal of Periodontal Research

Volumn 32, Issue 1 PART 2, 1997, Pages 183-188

  Shapira, L ^a   Houri, Y ^a   Barak, V ^b   Soskolne, W A ^a   Halabi, A ^a   Stabholz, A ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Lipopolysaccharide; Periodontal disease therapy; Tetracycline; TNF

Indexed keywords

ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; LIPOPOLYSACCHARIDE; TETRACYCLINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BIOSYNTHESIS; CHEMISTRY; DRUG ANTAGONISM; FEMALE; HUMAN; METABOLISM; MONOCYTE; MOUSE; PORPHYROMONAS GINGIVALIS;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; FEMALE; HUMANS; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED BALB C; MONOCYTES; PORPHYROMONAS GINGIVALIS; TETRACYCLINE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030631851     PISSN: 00223484     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0765.1997.tb01403.x     Document Type: Article

References (36)

1. Socransky SS, Haffajee AD. The bacterial etiology of destructive periodontal disease: current concepts. J Periodontol 1992; 63: 322-331.
2. Moore J, Wilson M, Kieser JB. The distribution of bacterial lipopolysaccharide (endotoxin) in relation to periodontally involved root surfaces. J Clin Periodontol 1986; 13: 748-751.
3. Fine DH, Morris ML, Tabak L, Cole JD. Preliminary characterization of material eluted from roots of periodontally diseased teeth. J Periodont Res 1980; 15: 10-19.
4. Wilson M, Moore J, Kieser JB. Identity of limulus amoebocyte lysate-active root surface materials from periodontally involved teeth. J Clin Periodontol 1986; 13: 743-747.
5. Maidwell-Smith M, Wilson M, Keiser JB Lipopolysaccharide (endotoxin) from individual periodontally involved teeth. J Clin Periodontol 1987; 14: 453-456.
6. Aleo JJ, DeRenzio FA, Farber PA, Varboncoeur AP. The presence and the biological activity of cementum bound endotoxin. J Periodontol 1974; 45: 672-675.
7. Fine DH, Mendieta C, Barnett ML, Furgany D, Naini A, Vincent JW. Endotoxin levels in periodontally healthy and diseased sites: correlation with levels of Gram-negative bacteria. J Periodontol 1992; 63: 897-901.
8. Olson RH, Adams DF, Layman DL. Inhibitory effect of periodontally diseased root extracts on the growth of human gingival fibroblasts. J Periodontol 1985; 56: 592-596.
9. Patters MR, Landesberg RL, Johansson LA, Trummel CL, Robertson PB. Bacteroides gingivalis antigens and bone resorbing activity in root surface fractions of periodontally involved teeth. J Periodont Res 1982; 17: 122-130.
10. Van Dyke TE, Lester MA, Shapira L. The role of host response in periodontal disease progression: implications for future treatment strategies. J Periodontol 1993; 64: 792-806.
11. Mundy GR. Inflammatory mediators and the destruction of bone. J Periodont Res 1991; 26: 213-217.
12. Mundy GR, Roodman GD, Bonewald LF, Yoneda T, Sabatini M. Effect of TNF and lymphotoxin on bone cells. In: Aggarwal BB, Vilcek J, eds Tumor necrosis factors. Structure, function and mechanism of action. New York: Marcel Dekker. Inc., 1992; 483-498.
13. Page RC. The role of inflammatory mediators in the pathogenesis of periodontal disease. J Periodont Res 1991: 26: 230-242.
14. Stashenko P, Fujiyoshi P, Obernesser MN, Prostak L, Haffajee AD, Socransky SS. Levels of interlcukin-1 beta in tissue from sites of active periodontal disease. J Clin Periodontol 1991; 18: 548-554.
15. Stashenko P, Jundinski JJ, Fujyoshi P, Rynar J, Socranski SS. Tissue levels of bone resorptive cytokines in periodontal disease. J Periodontol 1991; 62: 504-509.
16. Honig J, Rordorf-Adam C, Siegmund C, Wiedermann W, Erard F. Increased interleukin-1 beta concentration in gingival tissue from periodontitis patients. J Periodont Res 1989; 24: 362-367.
17. Offenbacher S, Odle BM, Van Dyke TE. The use of cervicular fluid PG E2 levels as a predictor of periodontal attachment loss. J Periodont Res 1986; 21: 101-112.
18. Offenbacher S, Soskolne WA, Collins JG. Prostaglandins and other eicosanoids in gingival cervicular fluid as a markers of periodontal disease susceptibility and activity. In: Johnson NW, ed. Risk markers for oral diseases: periodontal diseases. Cambridge: Cambridge University Press, 1991; 313-337.
19. Bone RC. The pathogenesis of sepsis. Ann Intern Med 1991; 115: 457-469.
20. Morrison DC, Ryan JL. Endotoxins and disease mechanisms. Ann Rev Med 1987; 38: 417-432.
21. Raetz CRH, Ulevitch RJ, Wright SD, Sibley CH, Ding A, Nathan CF. Gram-negative endotoxin: an extraordinary lipid with profound effects on eukaryotic signal transduction. FASEB J 1991; 5: 2652-2660.
22. Holt SC, Bramanti TE. Factors in virulence expression and their role in periodontal disease pathogenesis. Crit Rev Oral Biol Med 1991; 2: 177-281.
23. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990; 249: 1431-1433.
24. Shapira L, Takashiba S, Champagne C, Amar S, Van Dyke TE. Involvement of protein kinase C and protein tyrosine kinase in lipopolysaccharide-induced TNFa and IL-1b production by human monocytes. J Immunol 1994; 153: 1818-1824.
25. Weinstein SL, Sanghera JS, Lemke K, DeFranco AL, Pelech SL. Bacterial lipopolysaccharide induces tyrosine phosphorylation and activation of mitogen-activated protein kinases in macrophages. J Biol Chem 1992; 267: 14955-14962.
26. Mohler KM, Sleath PR, Fitzner JN, et al. Protection against a lethal dose of endotoxin by an inhibitor of tumor necrosis factor processing. Nature 1994; 370: 218-220.
27. Wikesjo UME, Baker PJ, Christersson LA, et al. A biochemical approch to periodontai regeneration: tetracycline treatment conditions root dentin surfaces. J Periodont Res 1986; 21: 322-329.
28. Golub LM, Ramamurthy NS, McNamara TF, Greenwald RA, Rifkin BR. Tetracycline inhibits connective tissue breakdown: new therapeutic implication for an old family of drugs. Crit Rev Oral Biol Med 1991; 2: 297-322.
29. Shapira L, Takashiba S, Amar S, Van Dyke TE. Porphyromonas gingivalis stimulation of human monocytes: dependence on serum and CD14 receptor. Oral Microbiol Immunol 1994; 9: 112-117.
30. Peritt D, Flechner I, Yanai P, et al. The M20 IL-1 inhbitor. II. Biological characterization. J Immunol Methods 1992; 155: 167-174.
31. Barak V, Peritt D, Flechner I, et al. The M20 IL-1 inhibitor prevents the onset of adjuvant arthritis. Biotherapy 1992; 4: 317-323.
32. Barak V, Peritt D, Yanai P, Halperin T. Treves AJ. In vivo anti inflammatory effects of the M20 IL-1 inhibitor. I. Effects of acute inflammatory parameters. Biotherapy 1994; 6: 263-270.
33. Shapira L, Takashiba S, Kalmar JR, Van Dyke TE, Barak V, Soskolne WA. Rapid fluorometric quantification of monocyte attachment in tissue culture wells. J Immunol Methods 1993; 165: 93-98.
34. Zhang X, Morrison DC. Pertussis toxin-sensitive factor differentially regulates lipopolysaccharide-induced tumor necrosis factor α and nitric oxide production in mouse peritoneal macrophages. J Immunol 1993; 150: 1011-1018.
35. Chang KM, Ramamurthy NS, McNamara TF, et al. Tetracycline inhibits Porphyromonas gingivalis-induced alveolar bone loss in rats by a non-antimicrobial mechanism. J Periodont Res 1994; 29: 242-249.
36. Webster GF, Toso SM, Hegemann L. Inhibition of a model of in vitro granuloma formation by tetracyclines and ciprofloxacin. Involvement of protein kinase C. Arch Dermatol 1994; 130: 748-752.